沙特阿拉伯王国政府所属的官方政府网站。
沙特官方政府网站的域名以下列后缀结尾 gov.sa
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
在数字政府管理局注册,编号:
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
Ensure the website is using the HTTPS protocol.
在数字政府管理局注册,编号:
| # | العنوان | التاريخ | نوع الخبر | رابط الخبر |
|---|---|---|---|---|
| 80 | Safety Signal of Hypokalemia associated with the use of Ceftriaxone | Signal | ||
| 79 | Safety Signal of Molluscum Contagiosum associated with the use of Fingolimod | Signal | ||
| 78 | Safety Signal of Rhabdomyolysis associated with the use of Pembrolizumab | Signal | ||
| 75 | Safety Signal of Skin Cancer associated with the use of Methotrexate | Signal | ||
| 81 | Baricitinib (Olumiant®) and increased risk of diverticulitis: Recommendations for Healthcare Professionals from the SFDA | Precautions | ||
| 76 | Safety Signal of Cardiac Failure associated with the use of Ibrutinib | Signal | ||
| 74 | Switching between Warfarin Brands and The Importance of Close Monitoring of INR | Precautions | ||
| 73 | Hydroxychloroquine and Chloroquine Alone and in Combination with Azithromycin and Potential Increased Risk of Heart Rhythm Problems | Warning | ||
| 72 | SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19 | Warning | ||
| 71 | SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19 | Precautions |
最后更新日期: 13/08/2026 at 10:30 上午 Saudi Arabia time
此页面尚未收到任何反馈。
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。